Al Faisaliah Group operates across dairy, electronics, healthcare, and food services sectors and has partnerships with global companies including Sony, Danone, and Philips. In 2025, its subsidiary Al Faisaliah Medical Systems Co. signed an exclusive agreement with Canada-based Profound Medical Corp. to distribute the TULSA-PRO® and Sonalleve® incision- and radiation-free ablative treatment technologies across Saudi Arabia. AFG also operates Al Faisaliah Ventures, a corporate venture capital arm investing in disruptive startups, with recent participation in Calo’s $39 million 2025 Series B extension.